IN2009CN00831A - - Google Patents

Download PDF

Info

Publication number
IN2009CN00831A
IN2009CN00831A IN831CHN2009A IN2009CN00831A IN 2009CN00831 A IN2009CN00831 A IN 2009CN00831A IN 831CHN2009 A IN831CHN2009 A IN 831CHN2009A IN 2009CN00831 A IN2009CN00831 A IN 2009CN00831A
Authority
IN
India
Prior art keywords
amino acid
human factor
substitution
factor vii
factor viia
Prior art date
Application number
Other languages
English (en)
Inventor
Jesper Mortensen Haaning
Kim Vilbour Andersen
Claus Bornaes
Original Assignee
Maxygen Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxygen Holdings Ltd filed Critical Maxygen Holdings Ltd
Priority claimed from PCT/DK2004/000428 external-priority patent/WO2004111242A1/en
Publication of IN2009CN00831A publication Critical patent/IN2009CN00831A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
IN831CHN2009 2004-06-18 2004-06-18 IN2009CN00831A (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DK2004/000428 WO2004111242A1 (en) 2003-06-19 2004-06-18 FACTOR VII OR VIIa GLA DOMAIN VARIANTS

Publications (1)

Publication Number Publication Date
IN2009CN00831A true IN2009CN00831A (ru) 2015-09-18

Family

ID=54398548

Family Applications (1)

Application Number Title Priority Date Filing Date
IN831CHN2009 IN2009CN00831A (ru) 2004-06-18 2004-06-18

Country Status (1)

Country Link
IN (1) IN2009CN00831A (ru)

Similar Documents

Publication Publication Date Title
IL172364A (en) Variant of vii or viia factor at gla site
PT1984357E (pt) Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
GB0625648D0 (en) Compounds
IS8485A (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
IL188803A0 (en) Low ph aerated products
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
TW200611702A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
ITRM20050265A1 (it) Protesi modulare perfezionata per osteosintesi, in particolare per l'osteosintesi dell'omero.
TNSN08024A1 (en) 7-substituted aza-indazoles, compositions containing same, production method and use thereof
WO2003104199A3 (en) ORGANIC CATALYST WITH IMPROVED SOLUBILITY
IL172773A0 (en) Formulations for the treatment of arhritis conditions
UA97346C2 (ru) Стабильная эмульсионная композиция
TW200724140A (en) Hydantoin compounds
UA89201C2 (ru) Энантиомеры выбранных конденсированных пиримидонов и их применение для лечения и профилактики злокачественного новообразования
MXPA04002636A (es) Barra de tocador teniendo un acidificador latente.
MX2007011327A (es) Empleo de 5'-metiltioadenosina (mta) en la prevencion y/o tratamiento de enfermedades autoinmunes y/o rechazo de transplantes.
BRPI0408446A (pt) tablete de limpeza
IN2009CN00831A (ru)
TW200603791A (en) Compounds and compositions as cathepsin S inhibitors
MXPA05012605A (es) Composiciones que comprenden compuestos de gastrina y sus usos en la diabetes.
MX2007005314A (es) Cetoles espirociclicos y su uso.
GB2434795A (en) Pyrrolo [2, 1-C] [1, 4] benzodiazepine-anthraquinone conjugates useful as antitumour agents
TW200603801A (en) Novel dialkoxy-imidazopyridines
TW200605895A (en) Combination of a selective noradrenaline reuptake inhibitor and a PDEV inhibitor